doi: 10.1161/01.CIR.0000162472.52990.36
(Circulation. 2005;111:2073-2085.)
© 2005 American Heart Association, Inc.
Heart Failure |
Progressive Attenuation of Myocardial Vascular Endothelial Growth Factor Expression Is a Seminal Event in Diabetic Cardiomyopathy
Restoration of Microvascular Homeostasis and Recovery of Cardiac Function in Diabetic Cardiomyopathy After Replenishment of Local Vascular Endothelial Growth Factor
From the Divisions of Cardiovascular Research and Cardiology, Caritas St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, Mass.
Correspondence to Douglas W. Losordo or Young-Sup Yoon, Cardiovascular Research, Caritas St. Elizabeth’s Medical Center, 736 Cambridge St, Boston, MA 02135. E-mail douglas.losordo{at}tufts.edu or young.yoon@tufts.edu
Received April 29, 2004; revision received November 22, 2004; accepted November 24, 2004.
Background— Diabetic cardiomyopathy (DCM) is characterized by microvascular pathology and interstitial fibrosis, which leads to progressive heart failure; however, the pathogenesis of DCM remains uncertain.
Methods and Results— Using the streptozotocin-induced diabetic rat model, we evaluated the natural course of DCM over a period of 1 year by serial echocardiography, Western blot analysis for vascular endothelial growth factor (VEGF), endothelial progenitor cell assays, myocardial blood flow measurements, and histopathologic analysis that included terminal dUTP nick end-labeling (TUNEL), capillary and cardiomyocyte density, and fibrosis area. Downregulation of myocardial VEGF expression preceded all other features of DCM and was followed by increased apoptosis of endothelial cells, decreased numbers of circulating endothelial progenitor cells, decreased capillary density, and impaired myocardial perfusion. Apoptosis and necrosis of cardiomyocytes ensued, along with fibrosis and progressive diastolic and then systolic dysfunction. To provide further evidence of the central role of VEGF in the pathophysiology of DCM, we replenished myocardial VEGF expression using naked DNA gene therapy via direct intramyocardial injection of plasmid DNA encoding VEGF (phVEGF165). VEGF-replenished rats showed increased capillary density, decreased endothelial cell and cardiomyocyte apoptosis, and in situ differentiation of bone marrow–derived endothelial progenitor cells into endothelial cells. These anatomic findings were accompanied by significant improvements in cardiac function.
Conclusions— These findings suggest that downregulation of VEGF may compromise microvascular homeostasis in the myocardium and thereby play a central role in the pathogenesis of DCM.
Key Words: diabetes • cardiomyopathy • growth substances • gene therapy • angiogenesis
This article has been cited by other articles:
 |
|
 |
|
  C. Whee Park, H. Wook Kim, J. Hee Lim, K. Dong Yoo, S. Chung, S. Joon Shin, H. Wha Chung, S. Ju Lee, C.-B. Chae, Y.-S. Kim, et al. Vascular Endothelial Growth Factor Inhibition by dRK6 Causes Endothelial Apoptosis, Fibrosis, and Inflammation in the Heart via the Akt/eNOS Axis in db/db Mice Diabetes, November 1, 2009; 58(11): 2666 - 2676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-Y. Song, Y.-J. Wu, Y.-J. Yang, J.-J. Li, H.-L. Zhang, H.-J. Pei, Z.-Y. Zhao, Z.-H. Zeng, and R.-T. Hui The accelerated post-infarction progression of cardiac remodelling is associated with genetic changes in an untreated streptozotocin-induced diabetic rat model Eur J Heart Fail, October 1, 2009; 11(10): 911 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Han, R. Baliga, H. Huang, P. J. Giannone, and J. A. Bauer Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H829 - H835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Messaoudi, P. Milliez, J.-L. Samuel, and C. Delcayre Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density FASEB J, July 1, 2009; 23(7): 2176 - 2185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-O. Jeong, M.-O. Kim, H. Kim, M.-Y. Lee, S.-W. Kim, M. Ii, J.-u. Lee, J. Lee, Y. J. Choi, H.-J. Cho, et al. Dual Angiogenic and Neurotrophic Effects of Bone Marrow-Derived Endothelial Progenitor Cells on Diabetic Neuropathy Circulation, February 10, 2009; 119(5): 699 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Tsagalou, M. Anastasiou-Nana, E. Agapitos, A. Gika, S. G. Drakos, J. V. Terrovitis, A. Ntalianis, and J. N. Nanas Depressed Coronary Flow Reserve Is Associated With Decreased Myocardial Capillary Density in Patients With Heart Failure Due to Idiopathic Dilated Cardiomyopathy J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1391 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Caporali, E. Pani, A. J.G. Horrevoets, N. Kraenkel, A. Oikawa, G. B. Sala-Newby, M. Meloni, B. Cristofaro, G. Graiani, A. S. Leroyer, et al. Neurotrophin p75 Receptor (p75NTR) Promotes Endothelial Cell Apoptosis and Inhibits Angiogenesis: Implications for Diabetes-Induced Impaired Neovascularization in Ischemic Limb Muscles Circ. Res., July 18, 2008; 103(2): e15 - e26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Makino, O. Platoshyn, J. Suarez, J. X.-J. Yuan, and W. H. Dillmann Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice Am J Physiol Cell Physiol, July 1, 2008; 295(1): C221 - C230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-h. Tuo, H. Zeng, A. Stinnett, H. Yu, J. L. Aschner, D.-F. Liao, and J.-X. Chen Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2547 - H2557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Weytjens, P. R. Franken, J. D'hooge, S. Droogmans, B. Cosyns, T. Lahoutte, and G. Van Camp Doppler myocardial imaging in the diagnosis of early systolic left ventricular dysfunction in diabetic rats Eur J Echocardiogr, May 1, 2008; 9(3): 326 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Spinetti, N. Kraenkel, C. Emanueli, and P. Madeddu Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies Cardiovasc Res, May 1, 2008; 78(2): 265 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Cheung, J. J. Wang, S. L. Rogers, F. Brancati, R. Klein, A. R. Sharrett, T. Y. Wong, and for the ARIC (Atherosclerosis Risk In Communities) Diabetic retinopathy and risk of heart failure. J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1573 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-F. Yeih, L.-Y. Lin, H.-I Yeh, Y.-J. Lai, F.-T. Chiang, C.-D. Tseng, S.-H. Chu, and Y.-Z. Tseng Temporal changes in cardiac force- and flow-generation capacity, loading conditions, and mechanical efficiency in streptozotocin-induced diabetic rats Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H867 - H874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rajasingh, E. Bord, H. Hamada, E. Lambers, G. Qin, D. W. Losordo, and R. Kishore STAT3-Dependent Mouse Embryonic Stem Cell Differentiation Into Cardiomyocytes: Analysis of Molecular Signaling and Therapeutic Efficacy of Cardiomyocyte Precommitted mES Transplantation in a Mouse Model of Myocardial Infarction Circ. Res., October 26, 2007; 101(9): 910 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Fadini, S. Sartore, C. Agostini, and A. Avogaro Significance of Endothelial Progenitor Cells in Subjects With Diabetes Diabetes Care, May 1, 2007; 30(5): 1305 - 1313. [Full Text] [PDF]
|
|
|
|
|
|
Y. Ruixing, Y. Dezhai, W. Hai, H. Kai, W. Xianghong, and C. Yuming Intramyocardial injection of vascular endothelial growth factor gene improves cardiac performance and inhibits cardiomyocyte apoptosis Eur J Heart Fail, April 1, 2007; 9(4): 343 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jesmin, S. Zaedi, N. Shimojo, M. Iemitsu, K. Masuzawa, N. Yamaguchi, C. N. Mowa, S. Maeda, Y. Hattori, and T. Miyauchi Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1030 - E1040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Wilson, M. Ii, K. W. Park, A. Suli, L. K. Sorensen, F. Larrieu-Lahargue, L. D. Urness, W. Suh, J. Asai, G. A.H. Kock, et al. Netrins Promote Developmental and Therapeutic Angiogenesis Science, August 4, 2006; 313(5787): 640 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rota, N. LeCapitaine, T. Hosoda, A. Boni, A. De Angelis, M. E. Padin-Iruegas, G. Esposito, S. Vitale, K. Urbanek, C. Casarsa, et al. Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66shc Gene Circ. Res., July 7, 2006; 99(1): 42 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jesmin, S. Zaedi, N. Yamaguchi, S. Maeda, N. Shimojo, K. Masuzawa, I. Yamaguchi, K. Goto, and T. Miyauchi Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart. Experimental Biology and Medicine, June 1, 2006; 231(6): 902 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. He, D. M. Opland, K. J. Way, K. Ueki, N. Bodyak, P. M. Kang, S. Izumo, R. N. Kulkarni, B. Wang, R. Liao, et al. Regulation of Vascular Endothelial Growth Factor Expression and Vascularization in the Myocardium by Insulin Receptor and PI3K/Akt Pathways in Insulin Resistance and Ischemia Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 787 - 793. [Abstract] [Full Text] [PDF]
|
|